Pharmaron vs Richter BioLogics: CDMO Comparison

How does Pharmaron compare to Richter BioLogics?

As of Nov 2026, Pharmaron: 5 FDA inspections (including 4 NAI, 1 VAI and 0 OAI), 1 EMA/MHRA GMP certificate. Signal Score 86.9. Richter BioLogics: no FDA inspections on file, 9 EMA/MHRA GMP certificates. Signal Score 82.9. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.

Side-by-side comparison of Pharmaron and Richter BioLogics on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score
87/100
Quality (FDA + GMP)
100/100
FDA inspections
5
— NAI / VAI / OAI
4 / 1 / 0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
1
Clinical programs (matched)
0
Capacity
Available
Modalities
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Hamburg, Germany
Signal Score
83/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
9
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
0
Capacity
—
Modalities
Plasmid DNA, Recombinant Proteins, VHH/Nanobodies, Bacterial Vaccines, Biologics, Microbial Fermentation

Key differences

  • Pharmaron has more FDA inspections on record (5 vs 0) — a deeper regulatory paper trail.
  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • Richter BioLogics holds 9 active EMA GMP certificates; Pharmaron does not appear in EudraGMDP.
  • Pharmaron maintains 1 MHRA / UK GMP certificate; Richter BioLogics does not.

Across the cross-modality scorecard, Pharmaron carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.

Frequently asked: Pharmaron vs Richter BioLogics

How does Pharmaron compare to Richter BioLogics?

On CDMO Signal's composite Signal Score, Pharmaron is 87/100 and Richter BioLogics is 83/100; Pharmaron has 5 FDA inspections on record vs 0 for Richter BioLogics; European coverage is 1 active EMA+MHRA certificate for Pharmaron vs 9 for Richter BioLogics. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

Which has the stronger FDA inspection record, Pharmaron or Richter BioLogics?

Both Pharmaron and Richter BioLogics maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Pharmaron has 5 FDA inspections on record; Richter BioLogics has 0.

How do Pharmaron and Richter BioLogics compare on European GMP coverage?

Pharmaron holds 0 active EMA GMP certificates and 1 MHRA / UK certificate. Richter BioLogics holds 9 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

What does the Signal Score gap mean in practice?

Pharmaron carries a Signal Score of 87/100 and Richter BioLogics carries 83/100 — essentially tied for Pharmaron. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating Pharmaron and Richter BioLogics for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.